# Study on the Safety and Effectiveness of Remimazolam Tosilate for Injection for Short-term Elective Surgery in Adults

> **NCT04908553** · PHASE4 · COMPLETED · sponsor: **Tongji Hospital** · enrollment: 650 (actual)

## Conditions studied

- Hypotension During Surgery

## Interventions

- **DRUG:** Remimazolam Tosilate for Injection 0.1mg/kg
- **DRUG:** Remimazolam Tosilate for Injection 0.15mg/kg
- **DRUG:** Remimazolam Tosilate for Injection 0.2mg/kg

## Key facts

- **NCT ID:** NCT04908553
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-01
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-05-31
- **Target enrollment:** 650 (ACTUAL)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04908553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04908553, "Study on the Safety and Effectiveness of Remimazolam Tosilate for Injection for Short-term Elective Surgery in Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04908553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*